Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.860
+0.0901.89%
Volume:67.70M
Turnover:327.34M
Market Cap:56.10B
PE:9.16
High:4.870
Open:4.820
Low:4.790
Close:4.770
Loading ...

CSPC Pharmaceutical Gets Marketing Nod for Glycemic Control Drug in China

MT Newswires Live
·
13 Jan

CSPC Pharmaceutical - Prusogliptin Tablets Obtains Marketing Approval Granted by Nmpa

THOMSON REUTERS
·
13 Jan

Earnings growth of 1.5% over 5 years hasn't been enough to translate into positive returns for CSPC Pharmaceutical Group (HKG:1093) shareholders

Simply Wall St.
·
11 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
10 Jan

BRIEF-CSPC Pharmaceutical Says SYS6041 Obtained Clinical Trial Approval

Reuters
·
10 Jan

CSPC Pharmaceutical - Sys6041 Obtains Clinical Trial Approval

THOMSON REUTERS
·
10 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYH2059 Tablets Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYS6045 Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

CSPC Pharmaceutical - Approval Granted by National Medical Products Administration

THOMSON REUTERS
·
07 Jan

CSPC Pharmaceutical - Syh2059 Tablets Obtains Clinical Trial Approval

THOMSON REUTERS
·
07 Jan

CSPC Pharmaceutical's Lung Cancer Drug Receives Breakthrough Therapy Designation in China

MT Newswires Live
·
03 Jan

BRIEF-CSPC Pharmaceutical Says SYS6010 Granted Breakthrough Therapy Designation In China

Reuters
·
02 Jan

Voluntary Announcement - Sys6010 Was Granted Breakthrough Therapy Designation in China

THOMSON REUTERS
·
02 Jan

CSPC Pharmaceutical Secures NMPA Approval for Tumor Drug

MT Newswires Live
·
31 Dec 2024

BRIEF-CSPC Pharmaceutical Says Leuprorelin Extended-Release Injection Obtains Clinical Trial Approval

Reuters
·
30 Dec 2024